Loading...

Stevanato Group S.p.A.

STVNNYSE
Healthcare
Medical - Instruments & Supplies
$21.99
$-0.63(-2.79%)

Stevanato Group S.p.A. (STVN) Stock Overview

Explore Stevanato Group S.p.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.4/100

Key Financials

Market Cap6B
P/E Ratio38.46
EPS (TTM)$0.57
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Week$21.81
1 Month$22.53
3 Months$18.46
1 Year Target$15.37

STVN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Stevanato Group S.p.A. (STVN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 37.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $15.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 38.46 and a market capitalization of 6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.34%
5-Day Change
8.71%
1-Month Change
-8.36%
3-Month Change
-9.72%
6-Month Change
13.05%
Year-to-Date (YTD) Change
-7.46%
1-Year Change
-28.59%
3-Year Change
5.29%
5-Year Change
5.29%
All-Time (Max) Change
5.29%

Contact Information

39 04 99 31 811
Via Molinella, 17, Piombino Dese, PD, 35017

Company Facts

5,521 Employees
IPO DateJul 16, 2021
CountryIT
Actively Trading

Frequently Asked Questions

;